You can find more information about PF3D7_0419900-PtdIns4K using the following links:

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
N-(2-(6-chloro-3-(4-methoxy-3-(morpholinothio)phenyl)-2-methyl-2,3-dihydroimidazo[1,2-b]pyridazin-8-yl)ethyl)acetamide	Structural Basis for Inhibitor Potency and Selectivity of Plasmodium falciparum Phosphatidylinositol 4-kinase Inhibitors(2020)
Sapanisertib	The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages(2022)